Physician profile
Matthew Keith Wingate
NPI 1871898239
$7,492.32
in general payments reported to CMS, 2019-2025
13 companies · $1,388 in 2025
The $1,388 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,080 · 2020: $67.79 · 2021: $4,764 · 2022: $129 · 2023: $63.59 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,016 · Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,016.12 |
| Food and Beverage | $435.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $3,675.94 | 2021-2022 | |
| Centinel Spine, LLC | $1,324.59 | 2025 | Prodisc L, Prodisc C Vivo |
| Globus Medical, INC. | $1,125.68 | 2019-2025 | Creo 5.5, Excelsius Gps, Attrax |
| Nuvasive, INC. | $770.35 | 2021 | |
| Spinal Elements, INC. | $295.15 | 2021 | |
| Abbott Laboratories | $72.20 | 2021-2025 | Eterna |
| Depuy Synthes Sales INC. | $56.54 | 2019 | |
| Medtronic USA, INC. | $41.64 | 2020 | |
| Ctl Medical Corporation | $31.80 | 2021 | |
| Arthrex, INC. | $30.96 | 2023 | |
| Seaspine Orthopedics Corporation | $26.15 | 2020 | |
| Medtronic, INC. | $25.21 | 2021 | |
| Titan Spine, LLC | $16.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Wingate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.